Frazier Life Sciences Acquisition Corp. II Completes IPO and Private Placement
Frazier Life Sciences Acquisition Corp. II announced the consummation of its initial public offering (IPO) and a concurrent private placement. The IPO involved the sale of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75,000,000. Additionally, 300,000 Class A ordinary shares were sold in a private placement to the Sponsor for $3,000,000. A total of $75,000,000 from these proceeds was placed in a U.S.-based trust account. The filing includes an audited balance sheet as of October 15, 2026, detailing assets of $76,837,481 and liabilities of $3,063,953.
